Annual report on transcatheter left atrial appendage closure in 2024_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

 BAI Yuan ¹ , ZHANG Xiaochun ² , ZENG Jie ³ , WU Yongjian ⁴ , ZHOU Daxin ² , Representatives of Structural Cardiology Committee of Cardiovascular Physicians Branch of Chinese Medical Doctor Association , National Clinical Research Center for Interventional Medicine , China Heart House

1. Department of Cardiology, Changhai Hospital, Navy Military Medical University, Shanghai, 200433, P. R. China;
2. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China;
3. Department of Cardiology, Sichuan Provincial People's Hospital, Chengdu, 610072, P. R. China;
4. Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, 100037, P. R. China;

Corresponding?author：

BAI Yuan, Email: yuanbai@smmu.edu.cn

Keywords：

Transcatheter left atrial appendage closure; interventional therapy; atrial fibrillation; annual report

DOI：

10.7507/1007-4848.202503024

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

After two decades of development, transcatheter left atrial appendage closure has emerged as a safe and effective intervention for stroke prevention in patients with atrial fibrillation. In 2024, significant advancements were made in the field of left atrial appendage closure in terms of evidence-based medicine, device research and development, and guideline consensus. The annual report on transcatheter left atrial appendage closure systematically reviews global academic progress in 2024, encompassing newly published clinical evidence, recently developed occlusion devices, and updated international guidelines/consensus statements. In the future, the development direction of transcatheter left atrial appendage closure mainly includes expanding surgical indications, optimizing imaging assistance technology, improving closure device design, and exploring individualized strategies for postoperative antithrombotic therapy.

Citation： BAI Yuan, ZHANG Xiaochun, ZENG Jie, WU Yongjian, ZHOU Daxin, Representatives of Structural Cardiology Committee of Cardiovascular Physicians Branch of Chinese Medical Doctor Association, National Clinical Research Center for Interventional Medicine, China Heart House. Annual report on transcatheter left atrial appendage closure in 2024. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2025, 32(6): 746-751. doi: 10.7507/1007-4848.202503024 Copy

1.	Wazni OM, Saliba WI, Nair DG, et al. Left atrial appendage closure after ablation for atrial fibrillation. N Engl J Med, 2025, 392(13): 1277-1287.
2.	Kapadia SR, Yeh RW, Price MJ, et al. Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR Left Atrial Appendage Occlusion Registry. Circ Cardiovasc Interv, 2024, 17(9): e013750.
3.	Kar S, Doshi SK, Sadhu A, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: Results from the PINNACLE FLX trial. Circulation. 2021, 143(18):1754-1762.
4.	Freixa X, Cruz-González I, Cepas-Guillén P, et al. Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: The ADALA randomized clinical trial. JAMA Cardiol, 2024, 9(10): 922-926.
5.	Reinhardt SW, Gibson DN, Hsu JC, et al. Anticoagulation alone vs anticoagulation plus aspirin or DAPT following left atrial appendage occlusion. J Am Coll Cardiol, 2024, 84(10): 889-900.
6.	Antúnez-Mui?os P, López-Tejero S, Cepas-Guillén P, et al. A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: The PLATEBRISK study. EuroIntervention, 2024, 20(16): 1018-1028.
7.	Aarnink EW, Maarse M, Fierro N, et al. Left atrial appendage occlusion in patients with anticoagulation failure vs anticoagulation contraindication. JACC Cardiovasc Interv, 2024, 17(11): 1311-1321.
8.	Aglan A, Fath AR, Maron BJ, et al. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm, 2024, 21(9): 1677-1683.
9.	Zhang T, Gao C, Liu J, et al. Impact of operator experience on left atrial appendage occlusion outcomes. JACC Clin Electrophysiol, 2024, 10(11): 2461-2470.
10.	Friedman DJ, Du C, Zimmerman S, et al. Procedure volume and outcomes with WATCHMAN left atrial appendage occlusion. Circ Cardiovasc Interv, 2024, 17(6): e013466.
11.	Du X, Chu H, Yang B, et al. Strategy optimization for a combined procedure in patients with atrial fibrillation: The COMBINATION randomized clinical trial. JAMA Netw Open, 2024, 7(11): e2445084.
12.	Zhang S, Xiong S, Zhang S, et al. WATCHMAN versus LACbes? device for percutaneous left atrial appendage closure: A single-center, propensity-matched study. BMC Cardiovasc Disord, 2025, 25(1): 18.
13.	Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2024, 45(36): 3314-3414.
14.	Korsholm K, Iriart X, Saw J, et al. Position statement on cardiac computed tomography following left atrial appendage occlusion. JACC Cardiovasc Interv, 2024, 17(15): 1747-1764.
15.	中華醫學會心電生理和起搏分會, 中國醫師協會心律學專業委員會, 左心耳封堵工作委員會. 左心耳干預預防心房顫動患者血栓栓塞事件: 目前的認識和建議(2023). 中華心律失常學雜志, 2023, 27(6): 463-489.Chinese Society of Pacing and Electrophysiology, Chinese Society of Arrhythmias, Working Committee on Occlusion of Left Atrial Appendage. Left atrial appendage intervention to prevent thromboembolic events in patients with atrial fibrillation: Current knowledge and recommendations (2023). Chin J Cardiac Arrhyth, 2023, 27(6): 463-489.
16.	儲慧民, 杜先鋒. 心腔內超聲心動圖指導左心耳封堵的規范化標準流程. 中華心臟與心律電子雜志, 2024, 12(1): 1-5.Chu HM, Du XF. The standard protocol of intracardiac echocardiography-guided left atrial appendage closure. Chin J Heart Heart Rhythm (Electron Ed), 2024, 12(1): 1-5.
17.	Wang Z, Chu H, Chen X, et al. Percutaneous left atrial appendage closure with SeaLA device in non-valvular atrial fibrillation. Catheter Cardiovasc Interv, 2024, 104(7): 1491-1498.
18.	Chen M, Yao PC, Fei ZT, et al. Prognostic impact of left atrial appendage patency after device closure. Circ Cardiovasc Interv, 2024, 17(5): e013579.
19.	Yao PC, Fei ZT, Chen M, et al. Incidence, impact and predictors of residual device patency after left atrial appendage closure with the LACbes device. Int J Cardiol, 2024, 397: 131640.

1. Wazni OM, Saliba WI, Nair DG, et al. Left atrial appendage closure after ablation for atrial fibrillation. N Engl J Med, 2025, 392(13): 1277-1287.
2. Kapadia SR, Yeh RW, Price MJ, et al. Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR Left Atrial Appendage Occlusion Registry. Circ Cardiovasc Interv, 2024, 17(9): e013750.
3. Kar S, Doshi SK, Sadhu A, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: Results from the PINNACLE FLX trial. Circulation. 2021, 143(18):1754-1762.
4. Freixa X, Cruz-González I, Cepas-Guillén P, et al. Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: The ADALA randomized clinical trial. JAMA Cardiol, 2024, 9(10): 922-926.
5. Reinhardt SW, Gibson DN, Hsu JC, et al. Anticoagulation alone vs anticoagulation plus aspirin or DAPT following left atrial appendage occlusion. J Am Coll Cardiol, 2024, 84(10): 889-900.
6. Antúnez-Mui?os P, López-Tejero S, Cepas-Guillén P, et al. A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: The PLATEBRISK study. EuroIntervention, 2024, 20(16): 1018-1028.
7. Aarnink EW, Maarse M, Fierro N, et al. Left atrial appendage occlusion in patients with anticoagulation failure vs anticoagulation contraindication. JACC Cardiovasc Interv, 2024, 17(11): 1311-1321.
8. Aglan A, Fath AR, Maron BJ, et al. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm, 2024, 21(9): 1677-1683.
9. Zhang T, Gao C, Liu J, et al. Impact of operator experience on left atrial appendage occlusion outcomes. JACC Clin Electrophysiol, 2024, 10(11): 2461-2470.
10. Friedman DJ, Du C, Zimmerman S, et al. Procedure volume and outcomes with WATCHMAN left atrial appendage occlusion. Circ Cardiovasc Interv, 2024, 17(6): e013466.
11. Du X, Chu H, Yang B, et al. Strategy optimization for a combined procedure in patients with atrial fibrillation: The COMBINATION randomized clinical trial. JAMA Netw Open, 2024, 7(11): e2445084.
12. Zhang S, Xiong S, Zhang S, et al. WATCHMAN versus LACbes? device for percutaneous left atrial appendage closure: A single-center, propensity-matched study. BMC Cardiovasc Disord, 2025, 25(1): 18.
13. Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2024, 45(36): 3314-3414.
14. Korsholm K, Iriart X, Saw J, et al. Position statement on cardiac computed tomography following left atrial appendage occlusion. JACC Cardiovasc Interv, 2024, 17(15): 1747-1764.
15. 中華醫學會心電生理和起搏分會, 中國醫師協會心律學專業委員會, 左心耳封堵工作委員會. 左心耳干預預防心房顫動患者血栓栓塞事件: 目前的認識和建議(2023). 中華心律失常學雜志, 2023, 27(6): 463-489.Chinese Society of Pacing and Electrophysiology, Chinese Society of Arrhythmias, Working Committee on Occlusion of Left Atrial Appendage. Left atrial appendage intervention to prevent thromboembolic events in patients with atrial fibrillation: Current knowledge and recommendations (2023). Chin J Cardiac Arrhyth, 2023, 27(6): 463-489.
16. 儲慧民, 杜先鋒. 心腔內超聲心動圖指導左心耳封堵的規范化標準流程. 中華心臟與心律電子雜志, 2024, 12(1): 1-5.Chu HM, Du XF. The standard protocol of intracardiac echocardiography-guided left atrial appendage closure. Chin J Heart Heart Rhythm (Electron Ed), 2024, 12(1): 1-5.
17. Wang Z, Chu H, Chen X, et al. Percutaneous left atrial appendage closure with SeaLA device in non-valvular atrial fibrillation. Catheter Cardiovasc Interv, 2024, 104(7): 1491-1498.
18. Chen M, Yao PC, Fei ZT, et al. Prognostic impact of left atrial appendage patency after device closure. Circ Cardiovasc Interv, 2024, 17(5): e013579.
19. Yao PC, Fei ZT, Chen M, et al. Incidence, impact and predictors of residual device patency after left atrial appendage closure with the LACbes device. Int J Cardiol, 2024, 397: 131640.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Annual report on transcatheter left atrial appendage closure in 2024

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content